Emsen, B. Et Al. 2018. The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma. Journal of Cancer Research and Therapeutics , vol.14, no.5 , 941-951.

Emsen, B., Aslan, A., TÜRKEZ, H., Joughi, A., & KAYA, A., (2018). The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma. Journal of Cancer Research and Therapeutics , vol.14, no.5, 941-951.

Emsen, Bugrahan Et Al. "The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma," Journal of Cancer Research and Therapeutics , vol.14, no.5, 941-951, 2018

Emsen, Bugrahan Et Al. "The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma." Journal of Cancer Research and Therapeutics , vol.14, no.5, pp.941-951, 2018

Emsen, B. Et Al. (2018) . "The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma." Journal of Cancer Research and Therapeutics , vol.14, no.5, pp.941-951.

@article{article, author={Bugrahan Emsen Et Al. }, title={The anti-cancer efficacies of diffractaic, lobaric, and usnic acid: In vitro inhibition of glioma}, journal={Journal of Cancer Research and Therapeutics}, year=2018, pages={941-951} }